Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A C Roos

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Pharmacy World & Science : PWS|October 18, 2005
Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: a case-control studyI Schillevoort, R M C Herings, G W K Hugenholtz, et al.
Human Molecular Genetics|June 5, 2002
Strong aggregation and increased toxicity of polyleucine over polyglutamine stretches in mammalian cellsJosephine C Dorsman, Barry Pepers, Dennis Langenberg, et al.
Journal of Neurology|July 21, 2016
Progression of motor subtypes in Huntington's disease: a 6-year follow-up studyM Jacobs, E P Hart, E W van Zwet, et al.
Journal of the Neurological Sciences|June 1, 2011
Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD studyS J A van den Bogaard, E M Dumas, L Ferrarini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 25, 2014
Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's diseaseJ A Bouwens, A A M Hubers, E van Duijn, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 22, 2007
Quality of life in couples living with Huntington's disease: the role of patients' and partners' illness perceptionsA A Kaptein, M Scharloo, D I Helder, et al.
Neurology|September 25, 2009
Normal and mutant HTT interact to affect clinical severity and progression in Huntington diseaseN A Aziz, C K Jurgens, G B Landwehrmeyer, et al.
Neurology|September 28, 2005
Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington diseaseJ C H van Oostrom, R P Maguire, C C Verschuuren-Bemelmans, et al.
Clinical Genetics|November 10, 2012
Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington's disease in the NetherlandsM C van Rij, C E M de Die-Smulders, E K Bijlsma, et al.
Journal of Neuroendocrinology|January 8, 2015
Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease and its association with depressive symptoms and suicidalityA A M Hubers, R C van der Mast, A M Pereira, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Pharmacy World & Science : PWS|October 18, 2005
Antipsychotic-induced extrapyramidal syndromes in psychiatric practice: a case-control studyI Schillevoort, R M C Herings, G W K Hugenholtz, et al.
Human Molecular Genetics|June 5, 2002
Strong aggregation and increased toxicity of polyleucine over polyglutamine stretches in mammalian cellsJosephine C Dorsman, Barry Pepers, Dennis Langenberg, et al.
Journal of Neurology|July 21, 2016
Progression of motor subtypes in Huntington's disease: a 6-year follow-up studyM Jacobs, E P Hart, E W van Zwet, et al.
Journal of the Neurological Sciences|June 1, 2011
Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD studyS J A van den Bogaard, E M Dumas, L Ferrarini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 25, 2014
Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's diseaseJ A Bouwens, A A M Hubers, E van Duijn, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 22, 2007
Quality of life in couples living with Huntington's disease: the role of patients' and partners' illness perceptionsA A Kaptein, M Scharloo, D I Helder, et al.
Neurology|September 25, 2009
Normal and mutant HTT interact to affect clinical severity and progression in Huntington diseaseN A Aziz, C K Jurgens, G B Landwehrmeyer, et al.
Neurology|September 28, 2005
Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington diseaseJ C H van Oostrom, R P Maguire, C C Verschuuren-Bemelmans, et al.
Clinical Genetics|November 10, 2012
Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington's disease in the NetherlandsM C van Rij, C E M de Die-Smulders, E K Bijlsma, et al.
Journal of Neuroendocrinology|January 8, 2015
Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease and its association with depressive symptoms and suicidalityA A M Hubers, R C van der Mast, A M Pereira, et al.
Pageof 5